New antipsychotic prescription and recurrent infections among adult sepsis survivors: A population‐based cohort study
Pharmacoepidemiology and Drug Safety · 2024-02 · 33 (2)
DOI: 10.1002/pds.5747 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 21.12.2023. Verfasst von Augusto Ferraris und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents, Sepsis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: ICES, Vanier Canada Graduate Scholarship.
Themen: Sepsis
Abstract (Originalsprache)
Purpose
Antipsychotic agents, which may increase the risk of infection through dopaminergic dysregulation, are prescribed to a fraction of patients following critical illness. We compared the rate of recurrent sepsis among patients who filled a prescription for antipsychotics with high‐ or low‐D 2 affinity.
Methods
Population‐based cohort with active comparator design. We included sepsis survivors older than 65 years with intensive care unit admission and new prescription of antipsychotics in Ontario 2008–2019. The primary outcome were recurrent sepsis episodes within 1 year of follow‐up. Patients who filled a prescription within 30 days of hospital discharge for high‐D 2 affinity antipsychotics (e.g., haloperidol) were compared with patients who filled a prescription within 30 days of hospital discharge for low‐D 2 affinity antipsychotics (e.g., quetiapine). Multivariable zero‐inflated Poisson regression models with robust standard errors adjusting for confounding at baseline were used to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI).
Results
Overall, 1879 patients filled a prescription for a high‐D 2, and 1446 patients filled a prescription for a low‐D 2 affinity antipsychotic. Patients who filled a prescription for a high‐D 2 affinity antipsychotic did not present a higher rate of recurrent sepsis during 1 year of follow‐up, compared with patients who filled a prescription for a low‐D 2 affinity antipsychotic (IRR: 1.12; 95% CI: 0.94, 1.35).
Conclusions
We did not find conclusive evidence of a higher rate of recurrent sepsis associated with the prescription of high‐D 2 affinity antipsychotics (compared with low‐D 2 affinity antipsychotics) by 1 year of follow‐up in adult sepsis survivors with intensive care unit admission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
- Laboratory of Applied Statistics in Health Sciences, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
- Epidemiology Department, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
- Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
- Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
ORCID-Profile: Augusto Ferraris
Förderung
- ICES
- Vanier Canada Graduate Scholarship
Zitieren
APA
Ferraris, A., Szmulewicz, A. G., Burry, L., Phipps, A., Wunsch, H., Scales, D. C., & Angriman, F. (2024). New antipsychotic prescription and recurrent infections among adult sepsis survivors: A population‐based cohort study. Pharmacoepidemiology and Drug Safety, 33(2). https://doi.org/10.1002/pds.5747
Vancouver
Ferraris A, Szmulewicz AG, Burry L, Phipps A, Wunsch H, Scales DC, et al. New antipsychotic prescription and recurrent infections among adult sepsis survivors: A population‐based cohort study. Pharmacoepidemiology and Drug Safety. 2024;33(2). doi:10.1002/pds.5747
BibTeX
@article{Ferraris2024,
author = {Ferraris, Augusto and Szmulewicz, Alejandro G and Burry, Lisa and Phipps, Amanda and Wunsch, Hannah and Scales, Damon C and Angriman, Federico},
title = {New antipsychotic prescription and recurrent infections among adult sepsis survivors: A population‐based cohort study},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
volume = {33},
number = {2},
doi = {10.1002/pds.5747}
}
EUVIMED